Completed initial public offering of common stock, raising approximately $190.0 million in gross proceedsFourth oncology Investigational New Drug (IND) application […]
Revenue grew 30%, despite COVID-19Continued to drive customer engagement without major sportsBOSTON, May 15, 2020 (GLOBE NEWSWIRE) — DraftKings Inc. […]
Non-Clinical Findings Suggest that Acelarin and NUC-3373 May Induce an Immune Response Against Cancer CellsAcelarin (NUC-1031) Releases DAMPs and Upregulates […]
AUSTIN, Texas,, May 15, 2020 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company […]
-Preclinical Data on Lead Immunotherapy Candidate NL-201 Including Immunogencity Results in Non-Human Primates-SEATTLE, May 15, 2020 (GLOBE NEWSWIRE) — Neoleukin […]